Navigation Links
Medicines360 and Camargo Pharmaceutical Gain FDA Approval for Intrauterine Contraceptive Device
Date:1/18/2016

CINCINNATI, Ohio, Jan. 18, 2016 /PRNewswire/ -- Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has helped Medicines360 gain FDA approval for their hormonal intrauterine contraceptive device.

Logo - http://photos.prnewswire.com/prnh/20160118/322993LOGO

"2015 was a very successful year: our (Medicines360) first NDA was approved and Camargo played a crucial role in this," said Andrea Olariu MD, PhD, Chief Medical Officer for Medicines360.

Medicines360's mission is to expand access to medicines for women regardless of their socioeconomic status, insurance status, or geographic location.

Medicines360's first approved product is a levonorgestrel-releasing intrauterine system (IUS), 52 mg. This IUS is a high quality product which will reach underserved women in 340B family planning clinics because it is being made available to these clinics at an affordable price of $50.

"We look forward to our continuing work with Medicines360 as they develop women's health products," said Ruth Stevens, PhD, MBA, Chief Scientific Officer and Executive Vice President at Camargo Pharmaceutical Services. "Our expertise in the 505(b)(2) approval pathway and drug development process is a great match for Medicines360 in helping them bring their products to market in a cost- and time-effective manner."

About Camargo Pharmaceutical Services

Camargo Pharmaceutical Services is the most experienced global strategist providing comprehensive drug development services specialized for the 505(b)(2) approval pathway and global equivalent processes. By assessing the scientific, medical, regulatory and commercial viability of product development opportunities, Camargo systematically builds and executes robust development plans that align with business strategies and ensure FDA buy-in every step of the way. Camargo routinely holds three to six pre-IND meetings a month, has over 200 FDA approvals and a 95% FDA concurrence rate, and works with product developers across more than 25 countries. Connect with Camargo on LinkedIn, read the company blog, and visit camargopharma.com for more information.

About Medicines360

Medicines360, located in San Francisco, California, is an innovative nonprofit global women's health pharmaceutical company with a mission to expand access to quality medicines for all women regardless of their socioeconomic status, insurance coverage or geographic location. Medicines360 is committed to working with healthcare providers, advocacy groups and patients to deliver innovative and meaningful treatments that help women around the world have greater access to the medicines they need. For more information, visit www.medicines360.org


'/>"/>
SOURCE Camargo Pharmaceutical Services
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Actavis and Medicines360 Announce Partnership to Advance Womens Access to Affordable IUDs
2. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
3. Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year
4. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
5. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
6. Access Pharmaceuticals Reports First Quarter Results
7. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
8. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
9. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
10. Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment
11. Aveo Pharmaceuticals, Inc. Sued by Investor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/18/2019)... AMERSHAM, United Kingdom and MALVERN, Pa. (PRWEB) , ... ... ... exciting series of complimentary seminars aimed at helping pharmaceutical companies reach meeting regulatory ... Events: What Rules & Regulations are Doing for TMF Health, Phlexglobal will host ...
(Date:7/17/2019)... , ... July 17, 2019 , ... Highmark Health, Allegheny ... soccer enthusiasts from around the region to announce plans for what will be one ... Located in Coraopolis on State Avenue and adjacent to the Montour Trail, the complex ...
(Date:7/17/2019)... , ... July 17, 2019 , ... The American Psychiatric ... Board of Directors and 2020 Nominating Committee . Elected by psychiatric-mental health nurse members ... APNA 33rd Annual Conference in New Orleans, LA, October 2-5, 2019. , “These ...
Breaking Medicine Technology:
(Date:7/17/2019)... CHICAGO (PRWEB) , ... July 17, 2019 , ... ... CEOs, presidents and administrators of critical access hospitals. , The men and women ... Several have overseen hospital expansions, mergers and EHR implementations as well as the ...
(Date:7/17/2019)... ... July 17, 2019 , ... This past Saturday, Monarch Dental® hosted ... . Over 50 underserved patients were welcomed at the Mesquite office to receive free ... summer season. Individuals were referred to the event through local nonprofit organizations such as ...
(Date:7/17/2019)... ... July 16, 2019 , ... A medical home care program ... need is key to better care for seniors. While this may not sound surprising, ... Home (LAJH) through its Brandman Research Institute (BRI) uncovered several surprising outcomes based on ...
(Date:7/13/2019)... ... July 13, 2019 , ... ZALO , the leading ... innovative rechargeable vibrator and clitoral massager. To view the product and its accompanying video ... and most advanced, personal massagers to people around the world,” said Mara Epstein, director ...
(Date:7/13/2019)... ... 2019 , ... China Focus @ Bio Philadelphia , ... Hangzhou Investment Promotion Bureau, Fox Rothschild LLP, MORE Health and Henlius, was held ... Pharmaceuticals, WuXi Biologics, Kelun Pharmaceutical, Harbin Pharmaceuticals, Fountain Medical, Luye Life Science, Johnson&Johnson, ...
Breaking Medicine News(10 mins):